All Access Articles |
- Completion of Enrollment in Phase 3 Cypress Study for Ampreloxetine | 2025-08-25 | PHARMACEUTICAL
- Theravance Biopharma's 10-Q Report Highlights Strategic Collaboration with Viatris | 2025-08-14 | PHARMACEUTICAL
- Theravance Biopharma secures approval for Yupelri in China | 2025-06-26 | PHARMACEUTICAL
- Theravance Biopharma's Strong Financial Performance in 10-K Report | 2025-03-07 | PHARMACEUTICAL